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Summary
 
Secondary lymphoid organ chemokine (SLC) is expressed in high endothelial venules and in T
cell zones of spleen and lymph nodes (LNs) and strongly attracts naive T cells. In mice ho-
mozygous for the paucity of lymph node T cell (
 
plt
 
) mutation, naive T cells fail to home to
LNs or the lymphoid regions of spleen. Here we demonstrate that expression of SLC is unde-
tectable in 
 
plt
 
 mice. In addition to the defect in T cell homing, we demonstrate that dendritic
cells (DCs) fail to accumulate in spleen and LN T cell zones of 
 
plt
 
 mice. DC migration to LNs
after contact sensitization is also substantially reduced. The physiologic significance of these ab-
normalities in 
 
plt
 
 mice is indicated by a markedly increased sensitivity to infection with murine
hepatitis virus. The 
 
plt
 
 mutation maps to the SLC locus; however, the sequence of SLC introns
and exons in 
 
plt
 
 mice is normal. These findings suggest that the abnormalities in 
 
plt
 
 mice are
due to a genetic defect in the expression of SLC and that SLC mediates the entry of naive T
cells and antigen-stimulated DCs into the T cell zones of secondary lymphoid organs.
Key words: CC chemokines • cellular immunity • leukocyte chemotaxis • T lymphocytes • 
mutation
 
S
 
econdary lymphoid organs are the predominant site of
lymphocyte sensitization to novel antigens. Their func-
tion requires the colocalization of two distinct populations of
 
leukocytes: antigen-presenting dendritic cells (DCs)
 
1
 
 and an-
tigen-responsive naive lymphocytes (1). Chemokines, a rap-
idly growing family of small chemotactic cytokines, are be-
lieved to provide the signals that guide leukocytes to their
proper location within lymphoid organs (2, 3). Several re-
cently identified chemokines have been suggested to mediate
the constitutive trafficking of leukocytes based on their in
vitro characteristics and their expression in lymphoid tissues
(4). A role for chemokines in B cell localization was shown
by a targeted disruption of the chemokine receptor Burkitt’s
lymphoma receptor 1 (5–8). However, the involvement of
chemokines in the localization of either T cells or DCs
within lymphoid organs has not been directly demonstrated.
DCs are distributed throughout the body at sites where
they can capture antigens (9). In response to an inflamma-
tory stimulus, these cells migrate into afferent lymphatics,
then are carried to draining LNs where they are deposited
in the subcapsular space. From the subcapsular space, DCs
migrate into T cell zones where they take up residence as
interdigitating DCs and present MHC-bound antigens and
costimulatory molecules to passing lymphocytes (10–15).
To sample this antigen repertoire, T lymphocytes that have
never been stimulated by antigen (naive T cells) migrate or
“home” specifically to the T cell zones of secondary lym-
phoid organs. In LNs and Peyer’s patches (PPs), lympho-
cytes leave the blood through specialized high endothelial
venules (HEVs) by a series of discrete steps which include
selectin-mediated rolling, integrin activation, integrin-
mediated firm adhesion, and endothelial extravasation (16,
17). In spleen, which lacks HEVs, lymphocytes exit the
blood in the marginal zone and migrate to the T cell zone
within the splenic white pulp by a poorly understood route
(18). Within the T cell zones of these lymphoid organs, a
 
1
 
Abbreviations used in this paper:
 
 AP, alkaline phosphatase; DC, dendritic
cell; ELC, EBV-induced molecule 1 ligand chemokine; HEV, high en-
dothelial venule; HPF, high power field; HRP, horseradish peroxidase;
MHV, murine hepatitis virus; PerCP, peridinine chlorophyll protein; 
 
plt
 
,
paucity of lymph node T cells; PP, Peyer’s patch; SA, streptavidin; SLC,
secondary lymphoid organ chemokine. 
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continuous flow of naive T cells sample the antigens pre-
sented by DCs. Most of these lymphocytes eventually return
to the circulation. The few that encounter their cognate an-
tigen are retained within the T cell zone, undergo clonal ex-
pansion, and differentiate into effector or memory T cells.
SLC (also known as 6Ckine, Exodus-2, and TCA4 [19–
22]) is a recently identified chemokine that is expressed in
the HEVs of LNs and PPs, in nondendritic stromal cells
within the T cell areas of LNs, spleen, and PPs, in the thy-
mic medulla, and in the lymphatic endothelium of multiple
tissues (22, 23). SLC has been hypothesized to mediate the
homing of naive lymphocytes to secondary lymphoid tis-
sues based on several findings (23). SLC is the only che-
mokine known to be constitutively expressed in the endo-
thelial cells of HEVs (23). SLC stimulates the chemotaxis of
naive T cells and, to a lesser extent, memory T cells and B
cells (23, 24). SLC stimulates both the 
 
a
 
L
 
b
 
2
 
 integrin–
mediated adhesion of T cells to intercellular adhesion mol-
ecule (ICAM)-1 and the 
 
a
 
4
 
b
 
7
 
 integrin–mediated adhesion
of these cells to mucosal addressin cell adhesion molecule
(MadCAM)-1 (23, 25, 26). Activated 
 
a
 
L
 
b
 
2
 
 function is es-
sential for lymphocyte homing to LNs and PPs, and acti-
vated 
 
a
 
4
 
b
 
7
 
 is required for homing to PPs. Under physio-
logic flow conditions, SLC stimulates the arrest of rolling T
cells with an efficiency and subset specificity (naive versus
memory) similar to that seen in vivo (27). These properties
strongly suggest that SLC mediates the homing of naive T
cells and perhaps other lymphocytes to secondary lymphoid
organs; however, this has not been demonstrated directly.
Recently, Nakano et al. described an autosomal recessive
mutation in mice, paucity of lymph node T cells (
 
plt
 
),
which leads to a defect in the homing of naive T lympho-
cytes to secondary lymphoid organs (28, 29). 
 
plt
 
 mice have
greatly decreased numbers of naive T lymphocytes in LNs,
PPs, and the white pulp of spleen. When injected into 
 
plt
 
mice, T lymphocytes from wild-type (
 
1
 
/
 
1
 
) mice fail to
enter LNs and PPs and accumulate only in the red pulp of
spleen, whereas lymphocytes from 
 
plt
 
 mice home normally
in 
 
1
 
/
 
1
 
 mice. These findings demonstrate that the 
 
plt
 
 de-
fect affects a gene expressed in the lymphoid organ stroma.
Although the exact mutation has not been identified, the
 
plt
 
 locus maps to mouse chromosome 4 in a region syntenic
to human chromosome 9p13. Two known human che-
mokine genes map to 9p13: SLC and EBV-induced mole-
cule 1 ligand chemokine (ELC) (19).
In view of the lymphocyte homing defects in 
 
plt
 
 mice,
we hypothesized that the 
 
plt
 
 mutation involves the murine
SLC gene. Here we report that SLC mRNA is not ex-
pressed in 
 
plt
 
 mice. We also explore the possibility that lack
of SLC expression in these mice leads to additional leuko-
cyte trafficking abnormalities. Hence, we also find that 
 
plt
 
mice have abnormalities in the localization of DCs within
lymphoid organs, in the migration of DCs to LNs, and are
severely immunocompromised. Our findings suggest that
the abnormalities in 
 
plt
 
 mice are due to a genetic defect in
the expression of SLC and that SLC is required for the en-
try of both naive T lymphocytes and antigen-bearing DCs
into the T cell zones of secondary lymphoid organs.
 
Materials and Methods
 
Reagents and Antibodies.
 
FITC (isomer 1) and LPS (serotype
055:B5) were obtained from Sigma Chemical Co. Metrizamide
A.G. was obtained from Accurate Chemical and Scientific Co.
The following anti–mouse antibodies were used for immunohis-
tochemistry and FACS
 
®
 
 analysis: biotinylated anti-CD11c, biotin-
ylated anti-IgM
 
a
 
,
 
 
 
biotinylated anti-B220, biotinylated anti-CD3,
biotinylated anti–I-Ad, FITC-conjugated anti–I-Ad, PE-conju-
gated anti–I-Ad, and anti-CD4 (PharMingen); NLDC-145 and
MOMA-1 (Bachem). The following secondary reagents were
used when applicable: avidin-conjugated FITC (avidin-FITC),
streptavidin-conjugated alkaline phosphatase (SA-AP), and SA-
conjugated horseradish peroxidase (SA-HRP; Vector Labs);
AP-conjugated goat anti–rat Ig (anti–rat Ig-AP; PharMingen);
HRP-conjugated goat anti–rat Ig (anti–rat Ig-HRP; Caltag Lab-
oratories); and SA-conjugated peridinine chlorophyll protein
(SA-PerCP; Becton Dickinson). Cells were suspended in RPMI/
25 mM HEPES/5% FCS unless otherwise noted.
 
Mice.
 
BALB/c-
 
plt
 
/
 
plt
 
 mice were produced by backcrossing
 
plt
 
 mice 10 generations into a BALB/c genetic background as de-
scribed previously (29). BALB/c control mice were obtained
from The Jackson Laboratory. All experiments were performed
on 6–10-wk-old age- and sex-matched mice maintained under
specific pathogen–free conditions.
 
RNA Expression Studies.
 
For Northern analysis, mRNA from
tissues of wild-type and 
 
plt
 
 mice was subjected to gel electrophore-
sis, transferred to Hybond-N
 
1
 
 membranes (Amersham Pharmacia
Biotech), and probed using randomly primed mouse SLC, ELC,
and actin cDNA. For in situ hybridizations, paraffin sections
(5 
 
m
 
m) from 
 
1
 
/
 
1
 
 and 
 
plt
 
 mice were deparaffinized, fixed in 4%
paraformaldehyde, and treated with proteinase K. After washing in
0.5
 
3
 
 SSC, the sections were covered with hybridization solution,
prehybridized for 1–3 h at 55
 
8
 
C, and hybridized overnight with
sense or antisense 
 
35
 
S-labeled riboprobe transcribed from the
mouse SLC or ELC cDNA. After hybridization, sections were
washed at high stringency, dehydrated, dipped in photographic
emulsion NTB
 
2
 
 (Eastman Kodak Co.), stored at 4
 
8
 
C for 8 wk, de-
veloped, and counterstained with hematoxylin and eosin.
 
Immunohistochemistry.
 
Tissue samples of spleen and LNs were
frozen in OCT, and 10-
 
m
 
m cryostat sections were prepared. Sec-
tions were fixed in acetone for 10 min, air dried, blocked with
PBS/5% normal goat serum for 30 min, and incubated with the
indicated primary antibodies for 1 h. Slides were then washed in
PBS, incubated with either SA-AP and anti–rat HRP or anti–rat
AP and SA-HRP for 30 min, and developed with 3,3’-diami-
nobenzidine (DAB) followed by Vector Red (Vector Labs) ac-
cording to the manufacturer’s instructions.
 
Flow Cytometry.
 
For DC quantitation, mesenteric, inguinal,
axillary, and brachial LNs from four 
 
plt
 
 and two 
 
1
 
/
 
1
 
 mice were
pooled, and single cell suspensions were prepared. RBCs were
depleted by lysis, and cells at 5 
 
3 
 
10
 
6
 
/ml were layered onto me-
trizamide (14.5 g/100 ml medium) and centrifuged for 10 min at
600 
 
g
 
. Cells at the interface were collected, washed, and resus-
pended in medium, stained with FITC-conjugated anti–I-Ad,
and analyzed by flow cytometry on a FACScan
 
®
 
 (Becton Dick-
inson). Spleen cells were isolated as described previously (30). In
brief, spleens were minced, incubated for 1 h at 37
 
8
 
C in RPMI
with 130 U/ml collagenase and 0.1 mg/ml DNase, teased
through 70-
 
m
 
m nylon mesh, and centrifuged. RBCs were de-
pleted by lysis, then cells were washed once and resuspended.
Cells were stained with FITC-conjugated anti–I-Ad, biotinylated
anti-B220, and biotinylated anti-CD3 followed by SA-PerCP
and analyzed by flow cytometry. For DC quantitation, cells 
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were gated against B220 and CD3 and analyzed for expression
of I-Ad.
 
Contact Sensitization.
 
The shaved abdomens of mice were
painted with 0.4 ml of 5 mg/ml FITC dissolved in a 50:50 (vol/
vol) mixture of acetone and dibutylphthalate. After 24 h, cell sus-
pensions of pooled inguinal, axillary, and brachial LNs were pre-
pared from each mouse and analyzed by flow cytometry. In some
experiments, aliquots of LN cells were stained with biotinylated
anti-CD11c followed by SA-PerCP. To determine I-A expres-
sion on FITC
 
1
 
 cells, aliquots of LN cells from four mice were
pooled, partially purified on metrizamide, stained with biotiny-
lated anti–I-Ad followed by SA-PerCP, and analyzed by flow cy-
tometry. For sensitization with a lower dose of antigen, 25 
 
m
 
l of
8 mg/ml FITC was spotted on the shaved right flank of five 
 
1
 
/
 
1
 
and five 
 
plt
 
 mice. After 24 h, the draining and contralateral in-
guinal LNs were removed and analyzed individually. Single cell
suspensions were quantitated, stained with anti–I-Ad and anti-
B220, and analyzed by flow cytometry.
 
Skin DC Migration and Staining.
 
Skin explant culture, prepa-
ration of dermal and epidermal whole mounts, and staining of
DCs were performed as described previously (31). In brief, ears
were rinsed with 70% ethanol and split with forceps into dorsal
and ventral halves. Dorsal ear halves were floated directly on 2 ml
of complete medium in 24-well plates for 3 d. Epidermal and
dermal sheets were prepared by floating ear halves (fresh or cul-
tured) or freshly prepared abdominal skin dermal side down on
0.5 M ammonium thiocyanate for 20 min at 37
 
8
 
C. Epidermis
was separated from dermis with fine forceps and stained immedi-
ately. Epidermal and dermal sheets were cut into 3 
 
3 
 
3–mm sec-
tions, fixed in acetone for 30 min, and rehydrated in PBS. They
were incubated in 1:20 biotinylated anti–I-Ad overnight at 4
 
8
 
C,
washed in PBS three times, and incubated with SA-FITC at
1:100 for 90 min at room temperature. After three washes, sheets
were mounted on microscope slides and evaluated by UV mi-
croscopy. Nonadherent migratory cells were recovered from the
bottom of tissue culture wells after 72 h by gentle rinsing. Ali-
quots were counted and cells were cytospun onto microscope
slides for staining with 1:100 biotinylated anti–I-Ad using a
Vectastain ABC kit (Vector Labs) and DAB and counterstained
 
with hematoxylin. The proportion of I-A
 
1
 
 cells was determined
by examining 10 fields/slide over 3 slides.
 
Viral Infection.
 
Mouse hepatitis virus, strain A59 (MHV-
A59), was propagated and plaque assayed on DBT cells as de-
scribed previously (32, 33). A single pool of virus was divided
into aliquots and stored at 
 
2
 
80
 
8
 
C until use. Mice were infected
by intraperitoneal injection of 0.2–2 
 
3 
 
10
 
6
 
 PFU of MHV-A59 in
a 0.2 ml vol. Mortality was assessed at 14 d after infection. LD
 
50
 
were calculated by the PROBIT method.
 
Sequence Analysis.
 
DNA fragments for sequencing were
generated by PCR amplification of genomic DNA from 
 
1
 
/
 
1
 
and 
 
plt
 
 mice with the following primer pairs (position of products
relative to transcriptional start site is listed in parentheses):
GTCAACCTGGTCTATGAATCCCAG and CACGACATC-
ACACTGAACCGATC (
 
2
 
1025 to 
 
2
 
428); GCTCAGCACTTA-
TGGAAGGGTG and GCCATGATTGTGGTTGAGTTGAG
(
 
2
 
598 to 59); TCTCACCTACAGCTCTGGTCTCATC and
GTGAACCACCCAGCTTGAAGTTC (12 to 779); CTGGA-
AAGAAAGGAAAGGGCTC and ATGGAGAGCAGGTTCA-
GGTCTTGG (571 to 1046); CTTCAACCATTACATCTG-
CACGG and TTTACTCCTGCCTGGGGATAGG (873 to 1965).
PCR was performed using a Perkin Elmer 9600 thermal cycler in
a final volume of 50 
 
m
 
l containing 5 U AmpliTaq enzyme with its
1
 
3
 
 buffer, 0.2 mM of each dNTP, and 1 
 
m
 
M of each primer.
Samples were heated to 94
 
8
 
C for 4 min, AmpliTaq was added,
and samples were cycled for 35 cycles at 94
 
8
 
C for 30 s, 60
 
8
 
C for
1 min, and 72
 
8
 
C for 1 min. PCR products were cloned into
PCRII TA (Invitrogen) according to the manufacturer’s instruc-
tions and sequenced using dye terminator technology.
 
Results
 
Lack of SLC Expression in plt Mice.
 
The expression pat-
tern of SLC mRNA and protein in normal mice has been
determined (22, 23). To examine the expression of SLC in
plt mice, in situ hybridization on tissue sections was per-
formed using 35S-labeled SLC antisense riboprobe. No
SLC mRNA was detected in any tissue of plt mice, includ-
Figure 1. SLC mRNA is not
expressed in plt mice. Sections of
paraffin-embedded tissues from
1/1 (A, C, and E) and plt (B,
D, and F) mice were hybridized
with  35S-labeled SLC antisense
riboprobe and exposed for 8 wk.
SLC hybridization signal (white
dots) can be seen in LN (A),
spleen (C), and PP (E) of 1/1
mice. No SLC signal is detected
in the LN (B), spleen (D), and
PP (F) of plt mice. f, lymphoid
follicles; t, T cell zone; RP, red
pulp. (G) Total RNA from pe-
ripheral LNs (PLN) and spleen
of 1/1 and plt mice was sub-
jected to Northern blot analysis
with 32P-labeled SLC probe and
subjected to autoradiography.
Blots were stripped and reprobed
with actin probe to determine
variability in gel loading.454 Leukocyte Trafficking in Mice Lacking SLC
ing LN, spleen, PP, thymus, and lymphatic endothelium,
whereas the location and abundance of SLC mRNA was
normal in the same tissues of 1/1 mice (Fig. 1, A–F, and
data not shown). Northern blot analysis of total RNA from
peripheral LNs and spleen confirmed the complete absence
of SLC transcripts in plt mice (Fig. 1 G).
Decreased Accumulation of DCs in the T Cell Zones of plt
Mice. plt mice have a defect in the homing of naive T
cells that leads to a marked decrease in the number of these
cells in the T cell zones of LNs, PPs, and spleen. The find-
ing that SLC is not expressed in plt mice strongly supports
the hypothesis that SLC is required for naive T cell hom-
ing. Like naive T cells, activated DCs migrate to the T cell
zones of secondary lymphoid organs. Therefore, we exam-
ined the distribution of DCs in plt mice. By FACS® analy-
sis, DC numbers were decreased 60% in the LNs of plt
mice (Fig. 2 A). The average number of total I-A1 DCs in
the pooled LNs of 1/1 mice was 24.5 6 4.7 3 103 per
mouse compared with 9.1 6 2.4 3 103 in plt mice (P ,
0.01, n 5 3). Immunohistochemistry established that this
decrease was most pronounced in the deep cortex. Those
DCs that were present in plt mice typically clustered in the
internodular cortex (Fig. 3, A and B). In the spleens of plt
mice, the total number of DCs was normal (Fig. 2 B), but
there was a striking abnormality in cell distribution (Fig. 3).
Staining with anti-CD11c revealed a marked decrease in
the number of DCs within the white pulp (Fig. 3, C and
D). There was a concomitant increase in the number of
Figure 2. (A) The number of DCs is decreased in LNs of plt mice. LNs
of 1/1 and plt mice were collected and centrifuged over metrizamide
gradients. Cells at the interface were collected, stained with FITC-conju-
gated anti–mouse I-Ad, normalized to the total number of cells per LN,
and analyzed by FACS® to detect I-A1 DCs (top right quadrant). One
representative experiment of three is shown. (B) The number of DCs is
normal in spleens of plt mice. Spleens of 1/1 and plt mice were col-
lected, dissociated with collagenase, and stained with FITC-anti–I-Ad,
biotinylated anti-B220, and biotinylated anti-CD3 followed by SA-
PerCP, normalized to the total number of cells per spleen, and analyzed
by flow cytometry. CD32, B2202 gated cells in one representative exper-
iment of three are shown.
DCs located outside the white pulp, either in bridging
channels or in isolated clusters within the red pulp, such
that the total number of splenic DCs remained normal.
Staining with NLDC-145, which in the spleen is specific
for interdigitating DCs (34), also revealed a decrease in
the number of these cells within the white pulp and dem-
onstrated that those DCs outside the white pulp were
NLDC-145 negative (Fig. 3, E and F).
Decreased Migration of DCs into T Cell Zones of plt Mice.
Interdigitating DCs in the T cell zones of LNs arise from DCs
in the periphery which migrate to this area via the lymph af-
ter activation. To determine if the paucity of interdigitating
cells observed in plt mice was due to a defect in the migration
of DCs to LNs, we examined this migration after contact sen-
sitization. 24 h after skin painting with 2 mg FITC, the fre-
quency of FITC1 cells in the draining LNs of plt mice was
markedly reduced compared with 1/1 mice (Fig. 4 A). The
identity of these cells as DCs was confirmed by their charac-
teristic forward and side scatter profiles, their staining with
anti-CD11c (Fig. 4 B) and anti–I-A (Fig. 4 C), and their low
buoyant density. A comparison of eight FITC-painted plt
mice with controls at 24 h revealed a 75% decrease in the
number of FITC1 DCs in draining LNs (Fig. 4 D).
Figure 3. DCs do not accumulate in the T cell zones of plt mice. The
distribution of DCs was examined in cryostat sections of 1/1 (A, C, and
E) and plt (B, D, and F) mice by immunohistochemistry. In LNs from 1/1
mice (A), NLDC-1451 DCs (red) are distributed uniformly throughout
the T cell zone (t). IgMa
1 B cells (brown) are shown for orientation.
When LNs from plt mice are stained similarly (B), DCs are found only in
the outer cortex between B cell follicles (f). In spleens of 1/1 mice (C),
numerous CD11c1 DCs (red) are seen within the white pulp (w). Mar-
ginal zones, which form the outer boundary of the white pulp, are identi-
fied by MOMA-1 staining (brown). In spleens of plt mice (D), few DCs
appear within the white pulp. In spleens of 1/1 mice (E), NLDC-1451
DCs (red) are seen within the T cell zone (t). IgMa
1 B cells (brown) are
shown for orientation. In plt spleen (F), few NLDC-1451 cells are seen.455 Gunn et al.
To ensure that the FITC signal in draining LNs was due
to the migration of DCs rather than FITC accumulation
within the LNs, we performed unilateral contact sensitiza-
tion with low dose (0.2 mg) FITC and compared contralat-
eral and draining LNs. In this procedure, resident (FITC2)
DCs can be distinguished from newly migrated (FITC1)
DCs (35). 24 h after skin painting, contralateral and drain-
ing LNs contained similar numbers of FITC2 DCs in both
1/1 and plt mice (Fig. 4 E). Similar to results shown
above, the number of resident DCs was decreased 60% in
plt mice. The draining LNs of painted mice demonstrated
accumulation of FITC1 I-A1 cells. In plt mice, the number
of these newly migrated FITC1 DCs was decreased 73%
compared with 1/1 mice (29.5 6 11 3 103 vs. 8.1 6 5.7 3
103, P 5 0.011, n 5 5).
To determine if the decreased accumulation of DCs in
the LNs of plt mice was secondary to a decreased number
of resident skin DCs, abdominal epidermis of 1/1 and plt
mice was stained with anti–I-A (Fig. 5, A and B). There
was no significant difference in the density, morphology, or
distribution of I-A1 DCs in the epidermis of untreated plt
and 1/1 mice. The average number of I-A1 epidermal
cells in 1/1 mice was 14 6 2.1 per high power field
(HPF) compared with 15.5 6 2.8 in plt mice.
We also examined the migration of splenic DCs upon
activation. Mouse spleen normally contains a population of
interdigitating DCs located within the T cell zone and a
separate population of DCs located in marginal zone bridg-
Figure 4. Decreased migration of skin DCs to LNs in plt mice after
contact sensitization with FITC. (A) The shaved abdomens of 1/1 and
plt mice were painted with 2 mg FITC. After 24 h draining LNs were re-
moved, dissociated, normalized to the total number of cells per LN, and
analyzed by flow cytometry. A decreased number of large FITC1 cells
(boxed area) can be seen in plt mice. One of eight representative experi-
ments is shown. (B) Representative FACS® profile showing a marked de-
crease of CD11c1 FITC1 cells in plt mice after FITC skin painting. (C)
Draining LN cells from FITC-painted mice were partially purified on me-
trizamide gradients, stained with biotinylated anti–I-Ad followed by
SA-PerCP, and analyzed by flow cytometry. Only large FITC1 cells
(boxed areas in A) are shown. (D) The number of FITC1 DCs (boxed areas
in A) that accumulate in LNs after skin painting with 2 mg FITC is
reduced in plt mice. Numbers represent mean 6 SD (n 5 8). (E) Compar-
ison of DC content in contralateral (CLN) and draining (DLN) inguinal
LNs in mice painted on one flank with 0.2 mg FITC. Single cell suspen-
sions were prepared from individual LNs, stained with anti–I-Ad and anti-
B220, and analyzed by flow cytometry gated on I-A1 B2202 cells.
Figure 5. (A and B) Whole mounts of abdominal epidermis from 1/1
(A) and plt (B) mice show normal numbers and distribution of DCs. Ab-
dominal epidermis was separated from dermis and stained with anti–I-Ad
(reference 31). (C and D) The accumulation of activated DCs in splenic T
cell zones is decreased in plt mice. Spleens of 1/1 (C) and plt (D) mice were
removed 6 h after intraperitoneal injection of LPS. Frozen sections were
prepared and stained for CD11c1 DCs (red) and B2201 B cells (brown).456 Leukocyte Trafficking in Mice Lacking SLC
ing channels and red pulp (30, 36, 37). Treatment of mice
with LPS has been shown to cause a rapid decrease in the
number of DCs located in bridging channels and red pulp
and a simultaneous increase in the number of interdigitating
DCs (38). This has led to the hypothesis that splenic DCs
outside the T cell zone represent an immature population
that migrates to the T cell zone upon activation. 6 h after in-
traperitoneal injection of LPS, spleens of 1/1 mice demon-
strated intense staining of DCs within T cell zones but few
DCs in bridging channels or red pulp (Fig. 5 C). By contrast,
the number of interdigitating cells in the splenic T cell zones
of plt mice did not increase after LPS treatment. Most DCs
remained scattered throughout the red pulp (Fig. 5 D).
Normal DC Migration out of Epidermis in plt Mice. SLC
is expressed (and therefore has the potential to mediate DC
migration) at two points along the migration route of DCs
from skin to LNs: in lymphatic endothelium and within
the T cell zone. To determine if plt mice have a defect in
the peripheral mobilization of DCs, we examined the mi-
gration of DCs out of cultured skin. Similar to our findings
in abdominal epidermis, dorsal ear epidermis from plt mice
contains a normal number of DCs (Fig. 6 E). When seg-
ments of dorsal ear skin were placed in culture, the number
of DCs within the epidermis of 1/1 and plt mice de-
creased to a similar extent over 72 h (Fig. 6, A, B, and E).
Over the same time period, the number of DCs within the
dermis increased similarly in plt and 1/1 mice (not shown).
As described previously (31), migrating DCs formed cords
within the dermal lymphatics of 1/1 mice (Fig. 6 C). A
similar formation of cords was seen in plt mice (Fig. 6 D),
demonstrating that the plt mutation does not inhibit the
entry of DCs into lymphatics. When the cells migrating out
of dorsal ear skin were collected over 72 h and counted,
the number of DCs released from the skin of plt and 1/1
mice was similar (Fig. 6 F).
Decreased Expression of ELC in plt Mice. ELC is the che-
mokine most closely related to SLC. ELC and SLC have
similar activities; both activate the CCR7 receptor, and
their genes are located within 100 kb of each other in the
human genome (24, 39, 40). In contrast to SLC, ELC ex-
pression is limited to interdigitating DCs in LNs and spleen
(41). To determine if the decreased accumulation of DCs
in plt mice leads to a decrease in the production of ELC,
we examined ELC expression in plt mice. By Northern
analysis, ELC mRNA levels in the LNs and spleen of plt
mice were reduced compared with 1/1 mice (Fig. 7 E).
By in situ hybridization, ELC expression was reduced in
the LNs of plt mice compared with 1/1 mice (Fig. 7, A
and B). ELC antisense probes hybridized most strongly to
the outer LN cortex in a region corresponding to the area
in which DCs accumulated in plt mice (compare Fig. 7 B
and Fig. 3 B). In the spleens of plt mice, ELC expression
was also reduced (Fig. 7, C and D). As in LNs, the hybrid-
ization signal in plt spleen localized to regions that corre-
spond to the area in which DCs accumulated (compare Fig.
7 D and Fig. 3 D). Similar to results in 1/1 mice, no ELC
signal was detected in lymphatics or any nonlymphoid tis-
sue of plt mice (data not shown).
plt Mice Have Decreased Resistance to Viral Infection. The
entry of lymphocytes and DCs into T cell zones is likely to
be a critical step in the development of a primary immune
response. Because plt mice have defects in lymphocyte and
DC migration, they are predicted to be deficient in mount-
ing such a response. To evaluate the response of plt mice to
viral infection, these mice were infected with MHV ad-
ministered by intraperitoneal injection. plt mice demon-
strate a markedly enhanced sensitivity to viral infection
(Fig. 8). At a dose of 20 PFU, which causes no mortality in
wild-type mice, 80% of the infected plt mice died. The
LD50 for MHV in wild-type mice was calculated to be
1,840 PFU. In plt mice the LD50 for MHV was 5.67 PFU,
a 300-fold decrease.
SLC Introns and Exons Are Intact in plt Mice. Although
the plt mutation (29) and the SLC gene (Gunn, M.D., un-
Figure 6. Migration of DCs out of skin explants is normal in plt mice.
Dorsal ear skin was floated on medium and cultured (reference 31). After
72 h, dermal and epidermal whole mounts were prepared and stained
with anti–I-Ad followed by SA-FITC. The density of DCs is similar in
the epidermis of 1/1 (A) and plt (B) mice after 72 h of culture. DC
cords form within dermal lymphatics of both 1/1 (C) and plt (D) mice
after 72 h of culture. (E) The density of DCs in epidermis decreases simi-
larly in 1/1 and plt mice over 72 h of culture. I-A1 cells were counted
in 20 fields/slide over 4 slides and calculated as the mean 6 SD of cells/
HPF. (F) Emigration of DCs out of cultured skin is normal in plt mice.
Nonadherent cells were collected from the bottom of wells in which ear
skin had been cultured for 72 h. Total cell number was determined by
counting on a hemocytometer. The proportion of DCs was calculated by
examining anti–I-Ad–stained cytospins of nonadherent cells. Results rep-
resent the mean 6 SD of DCs/well over four wells.457 Gunn et al.
published data) map to the same genetic locus on mouse
chromosome 4, the molecular basis of the plt mutation has
not been identified. To identify the genetic abnormality
that leads to a loss of SLC expression in plt mice, we have
initiated a search for the plt mutation at the DNA level.
The murine SLC gene contains four exons spanning a total
of 1 kb (Gunn, M.D., unpublished data). To determine if
the plt mutation occurs within SLC introns or exons, over-
lapping PCR fragments were generated from genomic
DNA of both plt and 1/1 mice. Comparison of plt and
1/1 sequence over a 3-kb region extending from 1 kb
upstream of the transcriptional start site to 1 kb down-
stream of the polyadenylation signal revealed several single
base changes but no mutation that would account for a loss
of SLC expression (data not shown). Thus, while the plt
mutation is located in the proximity of the SLC gene, it is
not within SLC introns or exons.
Discussion
Chemokines are implicated in two distinct steps in lym-
phocyte extravasation. First, they can stimulate integrin ac-
tivation and the firm adhesion of rolling lymphocytes. Sec-
ond, they can provide a chemotactic signal for lymphocyte
migration through the endothelium and into the underly-
ing tissue. We believe that SLC is the chemokine that me-
diates the first of these steps during the homing of naive T
cells to LNs and PPs. Evidence in support of this conclu-
sion includes the expression of SLC on HEVs, the ability of
SLC to activate both aLb2 and a4b7 integrins on T cells,
the ability of SLC to stimulate the rapid arrest of rolling T
cells with an efficiency similar to that seen in vivo, and the
absence of any other known chemokine with similar char-
acteristics. We now add to this body of evidence by dem-
onstrating that mice homozygous for the plt mutation do
not express SLC (Fig. 1). The lymphocyte homing defect
in plt mice is similar to that seen when naive T cells are
treated with pertussis toxin—failure of naive T cells to en-
ter LNs, PPs, or the white pulp of spleen, suggesting that
the defect in plt mice occurs in the initial steps of lympho-
cyte extravasation (29, 42, 43). Like pertussis toxin treat-
ment, the lymphocyte homing defect in plt mice probably
represents a loss of the signal for the integrin-mediated firm
adhesion of naive T cells.
Although the molecular mechanisms have not been elu-
cidated, naive lymphocytes are believed to enter the white
pulp of spleen by a series of adhesive and chemotactic steps
similar to those that occur in LNs. The lack of T cells in
the white pulp of spleen in plt mice suggests that SLC is
also required for the entry of naive T cells into the T cell
zones of spleen. By analogy with the defect seen in LNs, it
is plausible that SLC provides the stimulus for an integrin ac-
tivation step that is required for movement of naive T cells
into the white pulp of spleen. SLC may also provide a
chemotactic stimulus that guides naive T cells into the T cell
zones of LNs and spleen. However, this function is unlikely
to be unique, as other lymphocyte-specific chemokines such
as ELC and DCCK1 are expressed in T cell zones (41, 44).
ELC has been shown to be more potent than SLC against
Figure 7. Expression of ELC
mRNA is decreased in the LNs
and spleens of plt mice. Tissues
from 1/1 (A and C) and plt (B
and D) mice were analyzed as
described in the legend to Fig. 1.
ELC hybridization signal (white
dots) can be seen in LN (A) and
spleen (C) of 1/1 mice. The
intensity of ELC signal is re-
duced in the LN (B) and spleen
(D) of plt mice. f, lymphoid folli-
cles; RP, red pulp. (E) Northern
blot analysis. Total RNA from
peripheral LNs (PLN) and spleen
of 1/1 and plt mice was hybrid-
ized with 32P-labeled ELC probe
and subjected to autoradiogra-
phy. Blots were stripped and
reprobed with actin probe to de-
termine variability in gel loading.
Figure 8. Increased sensitivity of plt mice to MHV infection. Mice
were injected intraperitoneally with the indicated doses of MHV and
scored for mortality over the next 2 wk. Each data point represents at least
eight infected mice. The calculated LD50 for MHV infection of 1/1 and
plt mice are indicated.458 Leukocyte Trafficking in Mice Lacking SLC
naive T cells, and therefore may predominate in providing a
chemotactic stimulus within the T cell zone (39).
The involvement of SLC in naive lymphocyte homing
was initially suggested by its expression on HEVs (23). Simi-
larly, the expression of SLC at sites such as lymphatic endo-
thelium suggested to us that SLC may be involved in other
leukocyte trafficking events and that plt mice may have other
leukocyte trafficking defects. We now find that plt mice have
a defect in the migration of DCs into the T cell zones of
lymphoid organs. Four lines of evidence support this finding.
First, the number of DCs in the T cell zones of LNs and
spleen in plt mice is decreased (Fig. 3). In the spleen, this de-
crease occurs despite a normal total number of splenic DCs
(Fig. 2). Second, DCs appear to accumulate at the periphery
of T cell zones in both LNs and spleen of plt mice (Fig. 3).
The pattern of this accumulation is consistent with a block in
the entry of DCs into T cell zones. Third, we directly dem-
onstrate a decrease in the migration of FITC-activated DCs
to draining LNs of plt mice (Fig. 4). It is possible that this de-
fect in DC migration is secondary to the paucity of T cells in
the LNs of plt mice. However, in both L-selectin knockout
mice, which have a defect in the homing of naive lympho-
cytes to LNs similar to that of plt mice, and nude mice,
which lack mature T cells, FITC-stimulated migration of
DCs to LNs is normal (12, 35, 45, 46). This suggests that
DC migration to LNs is not lymphocyte dependent. Fourth,
splenic DCs in the bridging channels and red pulp of plt mice
fail to redistribute to the T cell zone upon activation with
LPS (Fig. 5, C and D). Taken together, these results suggest
that plt mice lack a factor that acts directly on DCs to stimu-
late their migration. Due to its lack of expression, the proba-
ble identity of this factor is SLC.
Because SLC is expressed in lymphatic endothelium, we
examined the possibility that the defect in DC migration
from skin to LNs in plt mice is due to an inability of activated
DCs to enter afferent lymphatics. Our findings argue against
this possibility, as DCs in skin cultured from plt mice were
able to migrate normally out of the epidermis, collect in
lymphatics, and move out of the skin in normal numbers
(Fig. 6). Although these results do not rule out the existence
of a subtle defect in the mobilization of peripheral DCs, they
suggest that the DC homing defect in plt mice occurs at the
level of DC entry into T cell zones. At present, the function
of SLC in lymphatic endothelium remains unknown.
Additional support for our conclusion that SLC is in-
volved in DC homing to T cell zones comes from recent
studies of chemokine receptor expression by DCs in vi-
tro (47–49). DCs derived in culture from monocytes or
CD341 precursors do not express CCR7, the receptor for
SLC and ELC. CCR7 expression is induced in these cells
by activation with LPS, CD40 ligand, or TNF. Similarly,
activated DCs increase intracellular calcium and undergo
chemotaxis in response to ELC. These results suggest that
immature DCs become responsive to SLC and ELC upon
activation in vivo and that one or both of these chemokines
is involved in the migration of activated DCs. It has been
suggested that it is the activation-induced downregulation
of chemokine receptors such as CCR1, CCR5, and CCR6
that allows DCs to leave sites of inflammation, whereas the
more gradual induction of CCR7 on these cells allows them
to enter T cell zones in response to ELC (47, 48). Our re-
sults support this hypothesis, though we would suggest that
SLC, rather than ELC, may play the predominant role.
Finally, we demonstrate that plt mice have a severe im-
mune deficiency. The LD50 of MHV in plt mice is reduced
.300-fold compared with 1/1 mice (Fig. 8). In compari-
son, the LD50 of Sendai virus is reduced 10-fold in mice
lacking cytotoxic T cell function and 300-fold in nude
mice compared with 1/1 controls (50). In our view, the
most likely cause of this immune deficiency is a defect in
the presentation of viral antigen due to the failure of naive
T cells and antigen-bearing DCs to enter the T cell zones
of plt mice. It is also possible that SLC, like some other
chemokines, provides a signal that enhances the antigen-
dependent activation of lymphocytes (51, 52). A third possi-
bility is that SLC, expressed in the thymus and in lymphatics,
has a role in lymphocyte development or in the efferent limb
of immune response that has not yet been characterized.
In this study, we cannot fully distinguish the biological
effects of SLC from those of ELC. Because SLC and ELC
signal through the same receptor, some of their functions
may overlap. plt mice express no detectable SLC mRNA
while ELC mRNA expression is only partially reduced
(Figs. 1 and 7), and the abnormalities observed in plt mice
are likely to be due to the sum of these defects. Still, some
conclusions can be drawn from our results. The near-total
loss of naive T cell homing in plt mice suggests an absolute
requirement for SLC and the existence of at least one func-
tion that cannot be performed by ELC. In contrast, plt
mice appear to exhibit only a partial defect in DC migra-
tion, suggesting that SLC and ELC may both contribute to
this process and that some DCs reach the T cell zone of plt
mice in response to low levels of ELC.
While we suggest that SLC is required for the normal
homing of naive T cells and DCs to secondary lymphoid or-
gans, we would emphasize that our findings do not consti-
tute proof of this hypothesis. It is possible that the plt muta-
tion directly affects the expression of a gene other than SLC
or ELC which is responsible for some of the phenotypic ab-
normalities observed in plt mice. Although the plt mutation
maps to the same genetic locus as SLC and plt mice express
no detectable SLC, no DNA abnormality has been identified
in these mice. Based on mapping data, the distance between
the plt mutation and the SLC gene is between 1 and 1,000
kb. Given their normal SLC intron and exon sequences, we
believe that the most likely cause of the lack of SLC expres-
sion in plt mice is a mutation involving a cis-acting regulatory
region of the SLC gene. Such regions do not have to be in
the immediate vicinity of the genes they regulate. For exam-
ple, the deletion of a region 50 kb upstream of the human
b-globin gene leads to a loss of its expression (53). Because
the plt mutation may involve a large deletion in the vicinity
of the SLC gene, we cannot rule out the possibility that this
defect involves more than one gene.
Despite this uncertainty, our working hypothesis contin-
ues to be that the genetic defect in plt mice represents a sin-459 Gunn et al.
gle-gene null mutation of SLC. Thus far, all of the recog-
nized abnormalities in plt mice occur in areas of SLC
expression and involve cell types known to be responsive to
SLC. This may change, as we are currently examining the
phenotype of plt mice in more detail while attempting to
identify the DNA abnormality responsible for the plt muta-
tion. At present, however, our findings strongly suggest that
SLC mediates the homing of both naive T cells and DCs to
secondary lymphoid organs and that the abnormalities in plt
mice are due to a genetic defect in the expression of SLC.
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